Iliac Vein Thrombosis
Conditions
Keywords
VTE, thrombophilia screening, patients, risk factors, post-thrombotic syndrome
Brief summary
Patients with previous diagnosis of iliac vein thrombosis are enrolled in this registry. Using standardized questionnaire, clinical data detailing venous thromboembolism and contributing VTE risk factors are recorded. Results of technical and laboratory investigations including screening of thrombophilic disorders were additionally entered into the database.
Interventions
GENETICthrombophilia screening
genetic Evaluation of Factor-V-Leiden, Factor-II\_G20210A Mutation;
Sponsors
Cardioangiologisches Centrum Bethanien
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* \>18 years * subjects with iliofermoral thrombosis, which has been proven by objective measurements (Duplex sonography, phlebography, CT/MRT) later than 1996
Exclusion criteria
* \<18 years * \> 80 years * surface or deep vein thrombosis without affection of pelvis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence and severity of postthrombotic Syndrome after iliofemoral thrombosis | up to 20 years after occurrence of iliofemoral thrombosis | The incidence and severity of postthrombotic Syndrome will be measured by te VILALLTA-Score |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Distribution of gender in Iliofemoral thrombosis | since 1996 | Distribution of gender (man or woman) |
| Distribution of affected side in Iliofemoral thrombosis | since 1996 | distribution of affected side (left or right side) |
| Disease-specific quality of life instrument for use in venous diseases of the leg (VEINES-QOL) | 1 year | A quality of life questionaire comprises 25 items that quantify disease effect on quality of life |
| Incidence of venous claudication | 1 year | Walking distance on treadmill |
Countries
Germany
Outcome results
None listed